Existence of an immunoglobulin G component of naturally occurring HLA class I antibodies that are not directed against self-antigens in human serum

Tissue Antigens

Volumn 72, Issue 2, 2008, Pages 98-104

  Zhou, B ^a   Saito, S ^b   Nakazawa, Y ^a   Kobayashi, N ^a   Matsuda, M ^a   Matsumoto, Y ^c   Hosoyama, T ^d   Koike, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japanese Red Cross Society   (Japan)

^c Veritas Corporation   (Japan)

^d ReproCELL Inc   (Japan)

Author keywords

Human leukocyte antigen antibody; Immunoglobulin G; Naturally occurring antibody; Systemic lupus erythematosus

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE; MALE; PREGNANCY; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SCREENING TEST; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; CHILD; FAMILY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 47549099388     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01074.x     Document Type: Article

References (25)

1. Vilá LM, Alarcón GS, McGwin G Jr. et al. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006 : 55 : 799 806.
2. Nakamura RM, Bylund DJ. Contemporary concepts for the clinical and laboratory evaluation of systemic lupus erythematosus and "lupus-like" syndromes. J Clin Lab Anal 1994 : 8 : 347 59.
3. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991 : 80 : 605 12.
4. Wenzel J, Gerdsen R, Uerlich M, Bauer R, Tueting T, Bieber T. Lymphocytopenia in lupus erythematosus: close in vivo association to autoantibodies targeting nuclear antigens. Br J Dermatol 2004 : 150 : 994 8.
5. al-Shahi R, Mason JC, Rao R et al. Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anaemia and anti-CD36 antibodies. Br J Rheumatol 1997 : 36 : 794 8.
6. Itoh Y, Sekine H, Hosono O et al. Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: clinical significance of anti-platelet antibodies. Clin Immunol Immunopathol 1990 : 57 : 125 36.
7. Saito S, Ota M, Komatsu Y et al. Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies. Transfusion 2003 : 43 : 908 17.
8. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993 : 329 : 1463 6.
9. Balduini CL, Salvaneschi L, Klersy C et al. Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. Leukemia 2001 : 15 : 1885 91.
10. Fabris F, Soini B, Sartori R, Randi ML, Luzzatto G, Girolami A. Clinical and laboratory factors that affect the post-transfusion platelet increment. Transfus Sci 2000 : 23 : 63 8.
11. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 : 337 : 1861 9.
12. Nakazawa Y, Saito S, Hasegawa Y et al. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia. Transfusion 2007 : 47 : 326 34.
13. Molokhia M, McKeigue P. Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res 2000 : 2 : 115 25. (Epub 24 February 2000).
14. Hirose S, Jiang Y, Nishimura H, Shirai T. Significance of MHC class II haplotypes and IgG Fc receptors in SLE. Springer Semin Immunopathol 2006 : 28 : 163 74. (Epub 14 September 2006).
15. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002 : 29 : 288 91.
16. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000 : 56 : 522 9.
17. Tongio MM, Falkenrodt A, Mitsuishi Y et al. Natural HLA antibodies. Tissue Antigens 1985 : 26 : 271 85.
18. Lenhard V, Diehm H, Römer W, Rauterberg EW, Kownatzki E, Roelcke D. A "spontaneous" cold-reactive IgM antibody with anti HLA-B8 specificity in a patient with multiple sclerosis. Immunobiology 1982 : 160 : 382 91.
19. Lepage V, Degos L, Dausset J. A "natural" anti-HLA-A2 antibody reacting with homozygous cells. Tissue Antigens 1976 : 8 : 139 42.
20. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995 : 7 : 812 8.
21. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991 : 12 : 154 9.
22. Scofield RH, Kurien B, Gross T, Warren WL, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet 1995 : 345 : 1542 4.
23. Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA. The Epstein-Barr virus Glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol 1988 : 27 : 367 71.
24. Takeuchi K, Tanaka-Taya K, Kazuyama Y et al. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol Int 2006 : 56 : 112 6.
25. Karpinski M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 2001 : 12 : 2807 14.